| P50 | author | Jean-Luc Pellequer | Q42212458 |
| P2093 | author name string | Xiao Xu | |
| | Subramanian Yegneswaran | |
| | John H Griffin | |
| | Andrew J Gale | |
| P2860 | cites work | Complete cDNA and derived amino acid sequence of human factor V | Q24605169 |
| | Proposed structural models of the prothrombinase (FXa-FVa) complex | Q28293819 |
| | The dynamics of thrombin formation | Q28610129 |
| | Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C | Q28631087 |
| | Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C | Q34305158 |
| | The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function | Q34829515 |
| | Proteases in blood clotting | Q35015141 |
| | Identification of functionally important residues in proteins using comparative models. | Q35698603 |
| | Mutating factor VIII: lessons from structure to function | Q35967952 |
| | Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. | Q36280112 |
| | Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C | Q38269759 |
| | The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. | Q38362540 |
| | Binding of substrate in two conformations to human prothrombinase drives consecutive cleavage at two sites in prothrombin | Q40502059 |
| | Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus | Q40506219 |
| | Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa. | Q42533684 |
| | Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex | Q44045917 |
| | Defining the factor Xa-binding site on factor Va by site-directed glycosylation | Q44183079 |
| | Analysis of the kinetics of prothrombin activation and evidence that two equilibrating forms of prothrombinase are involved in the process | Q44258994 |
| | Amino Acids Glu323, Tyr324, Glu330, and Val331 of Factor Va Heavy Chain Are Essential for Expression of Cofactor Activity | Q44435259 |
| | Binding site for blood coagulation factor Xa involving residues 311-325 in factor Va. | Q44798012 |
| | Prothrombin residues 473-487 contribute to factor Va binding in the prothrombinase complex | Q45032492 |
| | Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants | Q45858392 |
| | Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex | Q46097485 |
| | Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. | Q52485676 |
| | A control switch for prothrombinase: characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation. | Q53595426 |
| | Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation. | Q54102151 |
| | Soluble Phospholipids Enhance Factor Xa-Catalyzed Prothrombin Activation in Solution† | Q57977129 |
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drotrecogin alfa | Q412888 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 21848-21855 | |
| P577 | publication date | 2007-06-06 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site. | |
| P478 | volume | 282 | |